Cargando…

Evidence supporting the use of peptides and peptidomimetics as potential SARS-CoV-2 (COVID-19) therapeutics

During a disease outbreak/pandemic situation such as COVID-19, researchers are in a prime position to identify and develop peptide-based therapies, which could be more rapidly and cost-effectively advanced into a clinical setting. One drawback of natural peptide drugs, however, is their proteolytic...

Descripción completa

Detalles Bibliográficos
Autores principales:	VanPatten, Sonya, He, Mingzhu, Altiti, Ahmad, F Cheng, Kai, Ghanem, Mustafa H, Al-Abed, Yousef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Newlands Press Ltd 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364852/ https://www.ncbi.nlm.nih.gov/pubmed/32672061 http://dx.doi.org/10.4155/fmc-2020-0180

Ejemplares similares

SARS-CoV-2 and interferon blockade
por: Diamond, Betty, et al.
Publicado: (2020)

Thiocarbazate building blocks enable the construction of azapeptides for rapid development of therapeutic candidates
por: Altiti, Ahmad, et al.
Publicado: (2022)

Effects of novel muscarinic M3 receptor ligand C1213 in pulmonary arterial hypertension models
por: Ahmed, Mohamed, et al.
Publicado: (2016)

The Potential Therapeutic Application of Peptides and Peptidomimetics in Cardiovascular Disease
por: Recio, Carlota, et al.
Publicado: (2017)

Peptidomimetics Therapeutics for Retinal Disease
por: Parsons, Dylan E., et al.
Publicado: (2021)

Peptides and Peptidomimetics for Antimicrobial Drug Design
por: Mojsoska, Biljana, et al.
Publicado: (2015)

Macrocyclization strategies for cyclic peptides and peptidomimetics
por: Bechtler, Clément, et al.
Publicado: (2021)

Destinos : an introduction to Spanish /
por: VanPatten, Bill
Publicado: (1992)

Techniques assisting peptide vaccine and peptidomimetic design. Sidechain exposure in the SARS-CoV-2 spike glycoprotein
por: Robson, B.
Publicado: (2021)

Antibiofilm Peptides and Peptidomimetics with Focus on Surface Immobilization
por: Andrea, Athina, et al.
Publicado: (2018)

The Best Peptidomimetic Strategies to Undercover Antibacterial Peptides
por: Lachowicz, Joanna Izabela, et al.
Publicado: (2020)

Peptidomimetics and Their Applications for Opioid Peptide Drug Discovery
por: Lee, Yeon Sun
Publicado: (2022)

Peptides and peptidomimetics as a therapeutic candidate for the treatment of COVID-19: A brief review
por: Kumaravel, J., et al.
Publicado: (2023)

Oxetanyl Peptides: Novel Peptidomimetic Modules for Medicinal Chemistry
por: McLaughlin, Martin, et al.
Publicado: (2014)

Computational study on peptidomimetic inhibitors against SARS-CoV-2 main protease
por: Somboon, Tuanjai, et al.
Publicado: (2021)

Peptidomimetics II
por: Lubell, William D
Publicado: (2016)

Structure-based design, synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors
por: Ghosh, Arun K., et al.
Publicado: (2007)

Peptides and Peptidomimetics as Potential Antiobesity Agents: Overview of Current Status
por: Kumar, Maushmi S.
Publicado: (2019)

Bioinformatics and Biosimulations as Toolbox for Peptides and Peptidomimetics Design: Where Are We?
por: D’Annessa, Ilda, et al.
Publicado: (2020)

Editorial of Special Column “Novel Peptides and Peptidomimetics in Drug Discovery”
por: Cai, Jianfeng, et al.
Publicado: (2021)

Peptides and Peptidomimetics as Inhibitors of Enzymes Involved in Fibrillar Collagen Degradation
por: Ledwoń, Patrycja, et al.
Publicado: (2021)

Editorial: Improving antimicrobial peptides translational potential through peptidomimetics
por: Angeles-Boza, Alfredo M., et al.
Publicado: (2023)

Antimicrobial Peptidomimetics: Reinterpreting Nature to Deliver Innovative Therapeutics
por: Scorciapino, Mariano A., et al.
Publicado: (2012)

Structure-Based Design of Novel Peptidomimetics Targeting the SARS-CoV-2 Spike Protein
por: Alagumuthu, Manikandan, et al.
Publicado: (2020)

Peptidomimetic inhibitors of TMPRSS2 block SARS-CoV-2 infection in cell culture
por: Wettstein, Lukas, et al.
Publicado: (2022)

Exploiting Knowledge on Structure–Activity Relationships for Designing Peptidomimetics of Endogenous Peptides
por: Perez, Juan J.
Publicado: (2021)

Membrane-disruptive peptides/peptidomimetics-based therapeutics: Promising systems to combat bacteria and cancer in the drug-resistant era
por: Lin, Liming, et al.
Publicado: (2021)

Therapeutic Polypeptides and Peptidomimetics: Powerful Tools for COVID-19 Treatment
por: Liu, Xinyu, et al.
Publicado: (2022)

Peptidomimetics in cancer targeting
por: Gomari, Mohammad Mahmoudi, et al.
Publicado: (2022)

SARS-CoV-2 M(pro): A Potential Target for Peptidomimetics and Small-Molecule Inhibitors
por: Citarella, Andrea, et al.
Publicado: (2021)

Using Peptidomimetics and Constrained Peptides as Valuable Tools for Inhibiting Protein–Protein Interactions
por: Robertson, Naomi S., et al.
Publicado: (2018)

SPLUNC1 α6 Peptidomimetic: A Novel Therapeutic for Asthma
por: Vlahos, Ross
Publicado: (2021)

Synthetic and computational efforts towards the development of peptidomimetics and small-molecule SARS-CoV 3CLpro inhibitors
por: Paul, Abhik, et al.
Publicado: (2021)

Novel Polymyxin-Inspired Peptidomimetics Targeting the SARS-CoV-2 Spike:hACE2 Interface
por: Bugatti, Kelly, et al.
Publicado: (2023)

Development of Peptidomimetics Targeting IAPs
por: Sharma, Sushil K., et al.
Publicado: (2006)

Using the ribosome to synthesize peptidomimetics
por: Freidinger, Roger M
Publicado: (2009)

Short Cationic Peptidomimetic Antimicrobials
por: Kuppusamy, Rajesh, et al.
Publicado: (2019)

Promising Antibiofilm Activity of Peptidomimetics
por: Gomes Von Borowski, Rafael, et al.
Publicado: (2018)

Cell-free Biosynthesis of Peptidomimetics
por: Lee, Kanghun, et al.
Publicado: (2023)

Editor Profiles: Guest Editors of Special Column “Novel Peptides and Peptidomimetics in Drug Discovery”()
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_seo2bvods4hol8qhrnfsmdek0a